BIONECT ® Cream BIONECT ® Gel

Manufacturer
EPI Health, Inc
Effective date
2018-03-09
Label type
PRESCRIPTION MEDICAL DEVICE LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 02:48:52

Label at a glance#

ProductBionect
Active ingredientHyaluronate sodium
Label structure14 sections

Dosage and administration

The wounds or ulcers should be cleaned and disinfected prior to treatment. In the event of long-standing ulcers, it may be advisable to clean and/or to debride the wound by surgical or enzymatic means, prior to treatment. Apply a thin layer of BIONECT without extensive rubbing onto the wound surface, two or three times per day. Cover the lesion area with a sterile gauze pad and, if necessary, with an elastic or co...

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

For topical use only. Rx only.

Product Description

DESCRIPTION SECTION

BIONECT Cream is a white, viscous cream. BIONECT Gel is a clear, colorless gel. The principal component is the sodium salt of hyaluronic acid (0.2%). The sodium hyaluronate (Hyalastine®) is derived from a natural fermentation process. Hyaluronic acid is a biological polysaccharide (glycosaminoglycan) and is a major component of the extracellular matrix of connective tissues.

Indications

INDICATIONS & USAGE SECTION

BIONECT is indicated for the dressing and management of partial to full thickness dermal ulcers (pressure sores, venous stasis ulcers, arterial ulcers, diabetic ulcers), wounds including cuts, abrasions, donor sites, and post-operative incisions, irritations of the skin, and first and second degree burns. The dressing is intended to cover a wound or burn on a patient's skin, and protect against abrasion, friction, and desiccation.

Directions

DOSAGE & ADMINISTRATION SECTION

The wounds or ulcers should be cleaned and disinfected prior to treatment. In the event of long-standing ulcers, it may be advisable to clean and/or to debride the wound by surgical or enzymatic means, prior to treatment. Apply a thin layer of BIONECT without extensive rubbing onto the wound surface, two or three times per day. Cover the lesion area with a sterile gauze pad and, if necessary, with an elastic or compressive bandage.

Warnings

WARNINGS SECTION

If condition worsens, consult your physician immediately. Keep this product out of the reach of children. The prolonged use of the product may give rise to sensitization phenomena. Should this happen, discontinue the treatment and follow a suitable therapy. Do not use the product after the expiration date reported on the package or if the package is damaged.

Ingredients

SPL UNCLASSIFIED SECTION

BIONECT Cream

SPL UNCLASSIFIED SECTION

Hyaluronic acid sodium salt, polyethylene glycol 400 monostearate, decyl ester of oleic acid, emulsifying wax, glycerol, sorbitol solution 70%, sodium dehydroacetate, methylparaben, propylparaben, fragrance, purified water.

BIONECT Gel

SPL UNCLASSIFIED SECTION

Hyaluronic acid sodium salt, sorbitol solution 70%, sodium dehydroacetate, methylparaben, propylparaben, carbomer 980, sodium hydroxide, purified water.

Contraindications

CONTRAINDICATIONS SECTION

Do not administer to patients with known hypersensitivity to this product.

Interactions

DRUG INTERACTIONS SECTION

Do not use concomitantly with disinfectants containing quaternary ammonium salts because hyaluronic acid can precipitate in their presence. The concomitant topical treatment of wounds with antibiotics or other local agents has never given rise to interactions or incompatibilities with BIONECT.

Precautions

PRECAUTIONS SECTION

Avoid direct contact of container with the affected area. Each container of BIONECT should be used by one patient only in order to reduce the risk of cross infection.

WARNING

WARNINGS SECTION

Keep out of reach of children.

Adverse Reactions

ADVERSE REACTIONS SECTION

All suspected adverse reactions occurring during the treatment with BIONECT should be reported to your doctor.

How Supplied

HOW SUPPLIED SECTION

BIONECT Cream/Gel is supplied in a:

25g Cream - 71403-007-02
100g Cream - 71403-007-04
100g Gel - 71403-008-04

Storage

STORAGE AND HANDLING SECTION

BIONECT Cream may be stored for up to 24 months, BIONECT Gel may be stored for up to 24 months. Store at room temperature below 86°F (30°C).

SPL UNCLASSIFIED SECTION

Manufactured by: Fidia Farmaceutici S.p.A. - Italy

Distributed by: EPI Health, LLC
Charleston, SC 29403
1-800-499-4468
www.epihealth.com
www.Bionect.com

November 2017

Bionect and Hyalastine are registered trademarks of Fidia Farmaceutici S.p.A.

610386/H

PRINCIPAL DISPLAY PANEL - 100 g Tube Carton - Cream

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

71403-007-04

Rx Only
For Topical Use Only

Bionect®
(hyaluronic acid sodium salt, 0.2%) Cream

Net Wt 100g

Principal Display Panel - 100 g Tube Carton - Cream
Principal Display Panel - 100 g Tube Carton - Cream

PRINCIPAL DISPLAY PANEL - 100 g Tube Carton - Gel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

71403-008-04

Rx Only
For Topical Use Only

Bionect®
(hyaluronic acid sodium salt, 0.2%) Gel

Net Wt 100g

Principal Display Panel - 100 g Tube Carton - Gel
Principal Display Panel - 100 g Tube Carton - Gel

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
71403-007-02Bionect1 in 1 CARTON11
71403-007-02Bionect25 g in 1 TUBE251
71403-007-04Bionect1 in 1 CARTON11
71403-007-04Bionect100 g in 1 TUBE1001
71403-008-04Bionect100 g in 1 TUBE1001
71403-008-04Bionect1 in 1 CARTON11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
71403-007BIONECT (HYALURONATE SODIUM) BIONECT (HYALURONATE SODIUM) [EPI HEALTH, INC]14 package rows20180310_46547c4f-7513-4534-a85b-67105b3afd8e.zip
71403-008BIONECT (HYALURONATE SODIUM) BIONECT (HYALURONATE SODIUM) [EPI HEALTH, INC]12 package rows20180310_46547c4f-7513-4534-a85b-67105b3afd8e.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
71403-007-04GM - Gram71403-0079f66fce8-cb64-4ab3-8ef6-999035d35d8c12018-09-05
71403-008-04GM - Gram71403-0084c284ff2-59ea-4c2c-8e97-c7e5e3122eb912018-09-05

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 14 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
71403-00771403-007-04, 71403-007-02
71403-00871403-008-04

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 17 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CELISTAR MICRONEEDLING INFUSIONHYALURONATE SODIUMGuangdong Outeli Biotechnology Co., Ltd.53de46a7-3947-70a7-e063-6294a90ab8292026-06-09WarningsName fallback
generic name: HYALURONATE SODIUM

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.